Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Jacques-Olivier Pers; Juliette Coat; Julien Demoersman; Divi Cornec; Valérie Devauchelle-Pensec; Alain Saraux

Conference papers

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Jacques-Olivier Pers ¹ Juliette Coat ¹ Julien Demoersman ¹ Divi Cornec ^{2, 1} Valérie Devauchelle-Pensec ^{1, 2} Alain Saraux ^{1, 2}

1 EA2216 - Immunologie et Pathologie

2 CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie

Document type :

Conference papers

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadata

https://hal.univ-brest.fr/hal-01296598
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Friday, April 1, 2016 - 11:36:59 AM
Last modification on : Monday, March 28, 2022 - 12:10:05 PM

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Identifiers

Collections

Citation

Export

Metrics

34

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Identifiers

Collections

Citation

Export

Share

Metrics

34